ALVDX
Price
$11.11
Change
-$0.02 (-0.18%)
Updated
Aug 15 closing price
Net Assets
3.04B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

ALVDX vs VVIAX

Header iconALVDX vs VVIAX Comparison
Open Charts ALVDX vs VVIAXBanner chart's image
American Century Focused Lg Cap Val R6
Price$11.11
Change-$0.02 (-0.18%)
VolumeN/A
Net Assets3.04B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
ALVDX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ALVDX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVDX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. ALVDX (3.04B). VVIAX pays higher dividends than ALVDX: VVIAX (2.18) vs ALVDX (1.95). ALVDX was incepted earlier than VVIAX: ALVDX (12 years) vs VVIAX (25 years). ALVDX (0.49) is less costly to investors than VVIAX (0.05). ALVDX is a more actively managed with annual turnover of: 51.00 vs. VVIAX (9.00). ALVDX has a lower initial minimum investment than VVIAX: ALVDX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. ALVDX (4.46). VVIAX return over 5 years is better than : 68.54 vs. ALVDX (23.00).
ALVDXVVIAXALVDX / VVIAX
Total Expense Ratio0.490.05980%
Annual Report Gross Expense Ratio0.490.05980%
Fund Existence12 years25 years-
Gain YTD11.5646.517177%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.04B196B2%
Annual Yield % from dividends1.952.1890%
Returns for 1 year4.467.9156%
Returns for 3 years15.6825.9360%
Returns for 5 years23.0068.5434%
Returns for 10 years50.33114.6144%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp